About Pieter Wyckmans

Pieter Wyckmans provides expert advice to companies and organisations active in the (bio)pharmaceutical, biotech and smart devices sectors, and co-heads the life sciences department at QUINZ. His transactional expertise covers the entire life cycle of a drug product, including M&A, product divestments and licensing deals. Over the last few years, Pieter has developed regulatory expertise under EU and national laws. He advises clients on a broad array of legal and strategic issues regarding clinical trials and market access, including early access programmes, marketing authorisation procedures and pricing and reimbursement. Pieter previously worked in-house for the legal department of UCB.